The linear growth of 29 patients was evaluated from two to 4⅓ years after liver transplantation. All patients received cyclosporine and low-dose prednisone. Eight patients displayed acceleration of linear growth velocity and were above the fifth percentile at the end of the evaluation period. Four patients grew normally prior to transplantation and continued to grow normally after the surgical procedure. Only four patients dropped from higher levels to below the fifth percentile. Thirteen patients were less than the fifth percentile before and after surgery; ten of these 13 patients have attained normal or accelerated growth velocity. Good linear growth has been achieved in more than three fourths of patients who underwent liver transplanta...
We aimed to study the growth and growth factors of children with liver disease before and after live...
Sixty-five pediatric patients who received liver transplants between May 1981 and May 1984 were obse...
The new immunosuppressive agent, cyclosporin A, was used with low doses of steroids to treat eight p...
Objective—To assess growth in survivors of liver transplantation. Study design—Growth was studied in...
Objective: To evaluate the effect of end-stage pediatric liver disease and liver transplantation on ...
OBJECTIVE: To evaluate the effect of end-stage pediatric liver disease and liver transplantation on ...
Growth after pediatric liver transplantation is an important factor in determining the quality of li...
During a 24-month period (May 1981 to May 1983), 47 pediatric patients (ranging in age from 7 months...
WOS: 000296643400033PubMed ID: 21562786Aims Currently, the main interest in childhood liver transpla...
Two hundred fifty pediatric (<18 years of age) patients underwent orthotopic liver transplantation b...
One of the ultimate goals of successful solid organ transplantation in pediatric recipients is attai...
This paper reviews the past 50 years of liver transplantation in children from the perspective of pa...
Background. Children with primary hyperoxaluria type 1 (PH 1) often develop severe growth failure, w...
The aims of this study were to investigate outcome and to evaluate areas of potential ongoing concer...
The aims of this study were to investigate outcome and to evaluate areas of potential ongoing concer...
We aimed to study the growth and growth factors of children with liver disease before and after live...
Sixty-five pediatric patients who received liver transplants between May 1981 and May 1984 were obse...
The new immunosuppressive agent, cyclosporin A, was used with low doses of steroids to treat eight p...
Objective—To assess growth in survivors of liver transplantation. Study design—Growth was studied in...
Objective: To evaluate the effect of end-stage pediatric liver disease and liver transplantation on ...
OBJECTIVE: To evaluate the effect of end-stage pediatric liver disease and liver transplantation on ...
Growth after pediatric liver transplantation is an important factor in determining the quality of li...
During a 24-month period (May 1981 to May 1983), 47 pediatric patients (ranging in age from 7 months...
WOS: 000296643400033PubMed ID: 21562786Aims Currently, the main interest in childhood liver transpla...
Two hundred fifty pediatric (<18 years of age) patients underwent orthotopic liver transplantation b...
One of the ultimate goals of successful solid organ transplantation in pediatric recipients is attai...
This paper reviews the past 50 years of liver transplantation in children from the perspective of pa...
Background. Children with primary hyperoxaluria type 1 (PH 1) often develop severe growth failure, w...
The aims of this study were to investigate outcome and to evaluate areas of potential ongoing concer...
The aims of this study were to investigate outcome and to evaluate areas of potential ongoing concer...
We aimed to study the growth and growth factors of children with liver disease before and after live...
Sixty-five pediatric patients who received liver transplants between May 1981 and May 1984 were obse...
The new immunosuppressive agent, cyclosporin A, was used with low doses of steroids to treat eight p...